FR2206083A2 - Cytoplasmic metabolic factor - isolated from deproteinised and defatted animal or vegetable tissue - Google Patents
Cytoplasmic metabolic factor - isolated from deproteinised and defatted animal or vegetable tissueInfo
- Publication number
- FR2206083A2 FR2206083A2 FR7239967A FR7239967A FR2206083A2 FR 2206083 A2 FR2206083 A2 FR 2206083A2 FR 7239967 A FR7239967 A FR 7239967A FR 7239967 A FR7239967 A FR 7239967A FR 2206083 A2 FR2206083 A2 FR 2206083A2
- Authority
- FR
- France
- Prior art keywords
- deproteinised
- isolated
- metabolic factor
- vegetable tissue
- cytoplasmic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The prepn. of "cytoplasmic metabolic factor" (CMF) as described in the parent patent from animal or vegetable tissues, microorganisms and their culture media is improved by, before carrying out the chromatographic stages successively deproteinising and defatting the biological source matl. The prods. are activators of cell respiration and protect cells against ageing. Their additional use is in cosmetics for regeneration of tissues, and in treatment of hypoxia. Deproteinisation is carried out by treatment with ethanol, then centrifuging, defatting by CHCl3 extn.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7239967A FR2206083A2 (en) | 1972-11-10 | 1972-11-10 | Cytoplasmic metabolic factor - isolated from deproteinised and defatted animal or vegetable tissue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7239967A FR2206083A2 (en) | 1972-11-10 | 1972-11-10 | Cytoplasmic metabolic factor - isolated from deproteinised and defatted animal or vegetable tissue |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2206083A2 true FR2206083A2 (en) | 1974-06-07 |
FR2206083B2 FR2206083B2 (en) | 1977-03-25 |
Family
ID=9106990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7239967A Granted FR2206083A2 (en) | 1972-11-10 | 1972-11-10 | Cytoplasmic metabolic factor - isolated from deproteinised and defatted animal or vegetable tissue |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2206083A2 (en) |
-
1972
- 1972-11-10 FR FR7239967A patent/FR2206083A2/en active Granted
Non-Patent Citations (1)
Title |
---|
NEANT * |
Also Published As
Publication number | Publication date |
---|---|
FR2206083B2 (en) | 1977-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS57500830A (en) | ||
DK545584A (en) | ENZYM-RESISTANT IMMONUM MODULATORY PEPTIDES | |
DE69711893D1 (en) | ELECTROPORATION DEVICE WITH USER-CONFIGURED IMPULSES | |
DE69837491D1 (en) | HUMAN MESENCHYMAL STEM CELLS OF PERIPHERAL BLOOD | |
NL7609835A (en) | METHOD FOR INCREASING THE YIELD IN THE CULTURE OF TUBERIC CROPS AND APPARATUS FOR APPLYING THE METHOD | |
ATE191506T1 (en) | GENETHERAPEUTIC TREATMENT OF VASCULAR DISEASES USING A CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE | |
CA2141803A1 (en) | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen | |
ES8101557A1 (en) | N-Benzyl-imidazoles as selective inhibitors of the thromboxane synthetase enzyme | |
JPS6463505A (en) | Cosmetics | |
NL177501C (en) | APPARATUS FOR GROWING ANIMAL AND HUMAN TISSUES IN THE FORM OF SINGLE-CELL LAYERS AND OF VIRUSES ON THESE TISSUE CULTURES. | |
ES2151607T3 (en) | GROWTH AND DIFFERENTIATION FACTOR 12. | |
ATE17651T1 (en) | MIXTURE FOR HUMAN ADMINISTRATION OF SELENIUM AS A TRACE ELEMENT. | |
CA932664A (en) | Preservation of organs, tissues, and foodstuffs by means of biological protease inhibitors | |
JPS57117868A (en) | Method of combining biological active substance to carrier containing hydroxyl group | |
DK566883A (en) | PROCEDURE FOR PREPARING A WHOLE SACCHAROMYCES CEREVISIAE CELL CULTURE | |
FR2206083A2 (en) | Cytoplasmic metabolic factor - isolated from deproteinised and defatted animal or vegetable tissue | |
CH609863A5 (en) | Cosmetic treatment process and products enabling it to be carried out | |
SE7608103L (en) | PROCEDURE FOR CELL PROTEIN TREATMENT | |
ES8604774A1 (en) | Cosmetic composition obtained from connective tissue cell cultures. | |
JPS5231836A (en) | Beauty packs containing spirulina platensis | |
EVANS et al. | Studies of nutrient media for tissue cells in vitro. VI. The effect of the nucleic acid derivatives mixture of medium NCTC 109 on NCTC strain 2071 and NCTC strain 2981 | |
ATE6057T1 (en) | PLANT GROWTH REGULATOR COMPOSITIONS CONTAINING AS ACTIVE SUBSTANCE DERIVATIVES OF 2-METHYLENE SUCCINAMID ACID AND DERIVATIVES OF SUCH ACID USABLE IN SUCH COMPOSITIONS. | |
NZ182645A (en) | Continuously killing microorganisms in continuous culture of bacteria or yeast to produce single cell protein | |
JPS51142514A (en) | Materials for beauty culture and medicine consisting of the juice of n atural vegetables and fruits | |
GB1161722A (en) | Improvements in or relating to the Preparation of Enzyme Solutions |